Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Time for an Obituary or Not Just Yet!
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/content/pdf/10.1007/s12288-019-01077-x.pdf
Reference50 articles.
1. Harousseau JL, Attal M, Divine M, Marit G, Leblond V, Stoppa AM et al (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma. Blood 85(11):3077–3085
2. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P et al (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341(21):1565–1571. https://doi.org/10.1056/NEJM199911183412102
3. Kumar S (2017) Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies. Hematol Am Soc Hematol Edu Program 2017(1):518–524. https://doi.org/10.1182/asheducation-2017.1.518
4. Harousseau JL, Attal M (2017) How I treat first relapse of myeloma. Blood 130(8):963–973. https://doi.org/10.1182/blood-2017-03-726703
5. Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperley J et al (1996) Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 88(12):4711–4718
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural killer cell-based immunotherapy with CTLA4Ig-primed donor lymphocytes following haploidentical transplantation;Immunotherapy;2019-10
2. Targeting CD28-CD86 Pathway for Refractory Myeloma Through CTLA4Ig-Based Reduced-Intensity Conditioning and Donor Lymphocyte Infusions After Haploidentical Transplantation;Clinical Lymphoma Myeloma and Leukemia;2019-08
3. Stem Cell Transplantation in Multiple Myeloma: Very Much Alive and Kicking;Indian Journal of Hematology and Blood Transfusion;2019-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3